Scarica l'app Stockscreener
11.34
2.66%
-0.31
Precedente Chiudi:
$11.65
Aprire:
$11.69
Volume 24 ore:
119.93K
Relative Volume:
0.62
Capitalizzazione di mercato:
$388.45M
Reddito:
$7,000
Utile/perdita netta:
$-34.48M
Rapporto P/E:
-11.28
EPS:
-1.0054
Flusso di cassa netto:
$-22.13M
1 W Prestazione:
-2.66%
1M Prestazione:
-6.59%
6M Prestazione:
-8.47%
1 anno Prestazione:
+11.18%
Intervallo 1D:
$10.81
$11.72
Intervallo di 1 settimana:
$10.81
$12.25
Portata 52W:
$9.70
$17.15
Benitec Biopharma Inc Stock (BNTC) Company Profile
Nome
Benitec Biopharma Inc
Settore
Industria
Telefono
(510) 780-0819
Indirizzo
3940 TRUST WAY, HAYWARD, CA
Compare BNTC vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BNTC
Benitec Biopharma Inc
|
11.34 | 399.07M | 7,000 | -34.48M | -22.13M | -1.0054 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-07 | Iniziato | TD Cowen | Buy |
| 2024-12-16 | Iniziato | H.C. Wainwright | Buy |
| 2024-12-13 | Iniziato | Robert W. Baird | Outperform |
| 2024-10-16 | Iniziato | Oppenheimer | Outperform |
| 2024-09-12 | Iniziato | Guggenheim | Buy |
| 2024-07-22 | Iniziato | Leerink Partners | Outperform |
| 2024-06-13 | Iniziato | Piper Sandler | Overweight |
| 2020-10-05 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2020-04-20 | Iniziato | Ladenburg Thalmann | Buy |
| 2016-02-26 | Downgrade | Maxim Group | Buy → Hold |
| 2015-12-31 | Reiterato | Maxim Group | Buy |
| 2015-09-16 | Reiterato | Maxim Group | Buy |
Mostra tutto
Benitec Biopharma Inc Borsa (BNTC) Ultime notizie
Benitec Biopharma Releases Second Quarter 2026 Financial Results and Provides Operational Update - The Manila Times
BENITEC BIOPHARMA ($BNTC) Releases Q2 2026 Earnings - Quiver Quantitative
Benitec Biopharma Inc. SEC 10-Q Report - TradingView
Guidance Update: Is Benitec Biopharma Inc forming a breakout patternTreasury Yields & Technical Pattern Recognition Alerts - baoquankhu1.vn
Why (BNTC) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Benitec Biopharma (BNTC) Projected to Post Earnings on Friday - MarketBeat
Franklin Resources Inc. Expands Stake in Benitec Biopharma Inc. - GuruFocus
How liquid is Benitec Biopharma Inc stockWeekly Trade Analysis & High Accuracy Swing Trade Signals - baoquankhu1.vn
Benitec Biopharma Limited (NASDAQ:BNTC) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Income Plays: Is Benitec Biopharma Inc stock a good dividend stock2025 Key Lessons & Expert-Curated Trade Recommendations - baoquankhu1.vn
Benitec Biopharma: BB-301's Early OPMD Data And Cash Infusion Justify A Bullish Upgrade - Seeking Alpha
Meme Stocks: Is NATH stock a good pick for beginnersInflation Watch & Weekly High Return Forecasts - baoquankhu1.vn
BNTC Stockholders Sell Shares Without Benefit to Company - GuruFocus
Benitec Biopharma Inc. (BNTC) Investor Outlook: Analysts Predict Nearly 100% Upside Potential - DirectorsTalk Interviews
Benitec Biopharma (NASDAQ:BNTC) Stock Price Passes Below Fifty Day Moving AverageHere's Why - MarketBeat
Can Benitec Biopharma Inc. maintain its current growth rateJuly 2025 Patterns & Advanced Swing Trade Entry Alerts - mfd.ru
Understanding Momentum Shifts in (BNTC) - Stock Traders Daily
Analyst Downgrade: Should I average down on GBTG stockJuly 2025 Earnings & Safe Capital Allocation Plans - baoquankhu1.vn
Hedge Fund Bets: Is Benitec Biopharma Inc forming a double bottomJuly 2025 Catalysts & Short-Term High Return Ideas - baoquankhu1.vn
Benitec Biopharma Limited (NASDAQ:BNTC) Sees Large Increase in Short Interest - MarketBeat
Avoiding Lag: Real-Time Signals in (BNTC) Movement - Stock Traders Daily
Aug Setups: Will Benitec Biopharma Inc face regulatory challengesTrade Entry Report & Accurate Intraday Trading Signals - baoquankhu1.vn
Aug Gainers: How supply chain issues affect Benitec Biopharma Inc stockEarnings Summary Report & Free High Accuracy Swing Entry Alerts - Bộ Nội Vụ
Citizens reiterates Market Outperform rating on Benitec BioPharma stock By Investing.com - Investing.com Canada
Market Wrap: What is the PEG ratio of Benitec Biopharma Inc2025 Growth vs Value & AI Powered Market Entry Ideas - baoquankhu1.vn
Baird reiterates Outperform rating on Benitec BioPharma stock at $30 target - Investing.com Canada
Baird reiterates Outperform rating on Benitec BioPharma stock at $30 target By Investing.com - Investing.com South Africa
Benitec Biopharma (BNTC) Reports Promising Results from BB-301 S - GuruFocus
Benitec Biopharma Inc. Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response - marketscreener.com
Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response - Sahm
Can Benitec Biopharma Inc. stock double in next 5 years2025 Fundamental Recap & AI Forecasted Entry and Exit Points - ulpravda.ru
Benitec Biopharma Limited (NASDAQ:BNTC) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Benitec Biopharma Limited (NASDAQ:BNTC) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Is Benitec Biopharma Inc. stock a buy before product launches2025 Momentum Check & AI Forecasted Entry/Exit Points - Улправда
Why Benitec Biopharma Inc. stock could be next big winnerStraddle and Strangle Trades & Superior Capital Trading Plans - bollywoodhelpline.com
Published on: 2026-01-09 06:38:29 - Улправда
Is Benitec Biopharma Inc. stock a buy on dipsGap Up & Verified Swing Trading Watchlist - Улправда
Benitec Biopharma Inc. (BNTC) Investor Outlook: Exploring a 105.93% Potential Upside in Genetic Medicine - DirectorsTalk Interviews
Suvretta Capital Management, LLC Acquires Additional Shares in B - GuruFocus
Discipline and Rules-Based Execution in BNTC Response - Stock Traders Daily
Tahmar Enterprises Limited (516032) Announces Strategic ShiftReal-Time Stock Alerts & Free Stock Trading Workshops - earlytimes.in
Benitec Biopharma (NASDAQ:BNTC) Director Suvretta Capital Management, L Buys 16,836 Shares - Defense World
Suvretta Capital buys Benitec Biopharma (BNTC) shares for $1.9m By Investing.com - Investing.com Nigeria
Suvretta Capital Management, L Purchases 77,387 Shares of Benitec Biopharma (NASDAQ:BNTC) Stock - MarketBeat
Suvretta Capital buys Benitec Biopharma (BNTC) shares for $1.9m - Investing.com India
Does Benitec Biopharma (BNTC) Have the Potential to Rally 83.87% as Wall Street Analysts Expect? - Eastern Progress
Benitec Biopharma Inc Azioni (BNTC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Benitec Biopharma Inc Azioni (BNTC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 23 '25 |
Buy |
12.85 |
50,000 |
642,500 |
9,620,075 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 26 '25 |
Buy |
13.10 |
16,836 |
220,552 |
9,634,395 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 22 '25 |
Buy |
12.08 |
19,542 |
236,067 |
9,577,475 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 19 '25 |
Buy |
11.48 |
16,384 |
188,088 |
9,560,825 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 18 '25 |
Buy |
11.24 |
10,215 |
114,817 |
9,546,875 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Nov 07 '25 |
Buy |
13.50 |
1,481,481 |
19,999,994 |
9,538,175 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Mar 31 '25 |
Buy |
12.83 |
16,497 |
211,736 |
8,807,805 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Mar 26 '25 |
Buy |
13.00 |
900,000 |
11,700,000 |
8,793,245 |
| BUCHI J KEVIN | Director |
Feb 27 '25 |
Option Exercise |
3.86 |
51,813 |
199,998 |
103,910 |
1.24%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):